Clinical Trial Update: Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares Venetoclax with Azacitidine and Mitoxantrone hydrochloride liposome versus Idarubicin and Cytarabine in newly diagnosed acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)
• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)
• Venetoclax (venetoclax)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia (AML) | Phase 3 | Status: NOT_YET_RECRUITING